Medical cannabis origination and market access

Tell us what you need. We identify the supply worth reviewing.

Provenance helps licensed medical-cannabis purchasers source against a defined requirement. Send your product profile, quantity, destination and timing. We present relevant options, explain the fit and flag what still needs verification.

Free for buyers. Controlled introductions. No meeting required to get started. The portfolio uses anonymous product profiles and does not identify growers. It is not public inventory and does not represent live availability or regulatory approval.

Free access

Request confidential portfolio access

Seven quick questions. One at a time.

Start with a requirementWe identify the products worth qualification and flag the gaps.
Free for verified buyersThere is no access fee. We verify the requester before sharing private material.
Have a specific gap?Submit the profile and get a credible-fit, missing-information, or no-fit answer.
Portfolio first, or product gap first.

Browse the private combined view after verification, or send one procurement need for a focused fit screen.

Submit a buying requirement →

Already know the gap?

Submit the product profile you need.

A useful first screen begins with the requirement that could justify a match. Start with these four decision areas and add detail only where you already have it.

01 / Product

Define the product.

  • Flower or other available categories
  • Cultivar and cannabinoid range
  • Irradiated or non-irradiated
  • Quality specifications
02 / Market

Set the destination.

  • Destination country
  • Import pathway
  • Required certifications
  • Finishing or release pathway
03 / Supply

State the operating need.

  • One-time or recurring volume
  • Earliest required delivery
  • Minimum shelf life
  • Packaging requirements
04 / Commercial

Make the economics clear.

  • Target price or range
  • Incoterms, when relevant
  • Preferred origin
  • Other deal requirements

What the free first screen gives you

A clear next decision before an introduction.

For one buyer requirement, Provenance returns one of three answers: a credible anonymous capability worth advancing, missing information needed to screen responsibly, or no fit worth pursuing.

Illustrative requirement

Recurring flower requirement for a regulated destination

Non-irradiated flower within a defined THC range, 50 kg monthly, documented GACP, an identified GMP or QP release path, and a target delivered-price basis.

Potential fit
At most a small number of anonymous capabilities that appear aligned on product, cadence, treatment, and destination.
Evidence gaps
Current lot COA, recurring availability, certificate scope, price basis, and exact import or release responsibility still needing verification.
Decision
Advance to controlled diligence, clarify a missing term, or stop with a clear no-fit answer.

Hypothetical example of the screening method, not live inventory, a client result, or evidence of an approved regulatory or release route.

Before a product reaches a buyer

We review the fit.

Provenance does not simply forward every product received. We advance an opportunity when the product, available evidence, volume, timing, and economics appear relevant to an active requirement.

Final regulatory, quality, import, and product acceptance decisions remain with the licensed parties and relevant authorities.

01

Supplier and counterparty

We review the operating entity, relevant licenses, cultivation or production status, export capability, and the parties expected to perform the transaction.

02

Product

We collect available cultivar, cannabinoid, batch or forecast volume, harvest timing, COAs, specifications, shelf life, and commercial availability.

03

Documentation

We review documents supplied by the counterparty, which may include GACP or GMP information, export permissions, laboratory reports, stability data, traceability records, and finishing arrangements. We identify gaps and confirm key details with the relevant party.

04

Market fit

We compare the opportunity with the buyer's destination and stated requirements. A product that may suit one jurisdiction may not suit another.

05

Commercial fit

We review indicative pricing, quantity, recurring capacity, timing, finishing needs, and whether the opportunity appears realistic for the buyer.

International pipeline

Markets and supply origins currently represented.

This is a country-level view of active commercial relationships and qualification work. Counterparty names and exact locations remain private.

World map showing Provenance buyer markets and supply origins across Europe, North America, Latin America, Africa, Asia Pacific, and Israel
Buyer marketSupply originBuyer market and supply origin

Relationship depth and evidence vary by market. These locations do not represent completed transactions, confirmed inventory, approved export routes, or regulatory authorization.

From private access to a qualified introduction

Two ways in. One controlled path forward.

01 / Choose

Request access or send the gap

Open with the private portfolio, or share a specific product, destination, volume, timing, and non-negotiable terms.

02 / Verify

Confirm the starting point

For portfolio access, we verify your role and company. For a requirement, we return a credible-fit, missing-information, or no-fit answer.

03 / Review

Control the diligence

Before identity or restricted evidence is disclosed, the relevant route, authority, commercial terms, and protections must be clear.

04 / Introduce

Qualified introduction

When both sides want to proceed, the parties conduct direct commercial, quality, legal, and regulatory diligence.

Built for procurement, not browsing

One opportunity or a recurring program.

Some buyers need a single lot. Others need dependable monthly supply. We screen both, with particular attention to volume consistency, timing, documentation, and commercial fit.

Recurring monthly programsReplacement supplyAlternative originsSpecific cannabinoid rangesNew cultivarsSupplementary lotsBackup suppliersFinishing pathways

Specific product gap

Get a free screen of one procurement need.

Start with the decision-making information. We will tell you what appears relevant, what is missing, or why there is no credible fit. Technical detail can be added after the first review.

No meeting required
No fee or obligation for the initial screen
No supplier identity disclosed before the path is protected

Submit the product profile

Seven required inputs. Add only the technical detail you already have.

Free initial screen
Add product, documentation, and commercial details Optional

Do not upload or paste patient data, identity documents, certificates, or other confidential files. We will arrange a controlled channel if the requirement advances.

For export-ready suppliers

Find out whether your product fits actual buyer requirements.

We selectively take products to market based on commercial fit, documentation and a credible destination pathway. Start with a free Supplier Fit Screen. You will receive the main blockers and a recommended next step.

Qualified products may enter a 10-business-day Buyer Fit Sprint for USD $2,500, credited against our success fees starting with the first qualifying transaction. The standard success fee is 5%, including qualifying repeat business under the agreement.

Request a free Supplier Fit Screen

Existing supplier agreements remain unchanged. No guaranteed introductions or sales.

How Provenance works

Buyer-led origination. Controlled market access.

Provenance Global Trade Network LLC is a non-custodial commercial origination and market-access business. We help counterparties assess fit, prepare commercial information and coordinate protected introductions. Buyers and suppliers contract and transact directly. Provenance does not take title to, hold or ship cannabis, issue regulatory approvals or provide legal advice.

Buyers submit requirements and review products for free. Suppliers pay for agreed commercial work and qualifying transactions. Supplier payment does not determine our recommendations.